ConductScience.org, home

Paper23744404

Lack of reduction of left ventricular mass in treated hypertension: the strong heart study.

de Simone G and 6 others. J Am Heart Assoc, 2013. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. Papers, record 23744404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23744404

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lack of reduction of left ventricular mass in treated hypertension: the strong heart study.
PubMed
Journal
J Am Heart Assoc
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
2.26
iCite
Revised in PubMed
2021-10-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Simone GGiovanni
2Devereux RBRichard B
3Izzo RRaffaele
4Girfoglio DDaniela
5Lee ETElisa T
6Howard BVBarbara V
7Roman MJMary J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
HypertensionMajor topic
Hypertrophy, Left VentricularMajor topic
Aged
Female
Follow-Up Studies
Humans
Longitudinal Studies
Male
Middle Aged

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HL65521NHLBI NIH HHSUnited StatesU01HL065521PubMed and NIHNIH RePORTER
U01 HL041642NHLBI NIH HHSUnited StatesU01HL041642PubMed and NIHNIH RePORTER
M01 RR000047NCRR NIH HHSUnited StatesM01RR000047PubMed and NIHNIH RePORTER
U01 HL065521NHLBI NIH HHSUnited StatesU01HL065521PubMed and NIHNIH RePORTER
HL41652NHLBI NIH HHSUnited StatesU01HL041652PubMed and NIHNIH RePORTER
U01 HL041654NHLBI NIH HHSUnited StatesU01HL041654PubMed and NIHNIH RePORTER
U01 HL041652NHLBI NIH HHSUnited StatesU01HL041652PubMed and NIHNIH RePORTER
M10RR0047-34NCRR NIH HHSUnited StatesM10RR004734PubMedNIH RePORTER
HL41642NHLBI NIH HHSUnited StatesU01HL041642PubMed and NIHNIH RePORTER
HL41654NHLBI NIH HHSUnited StatesU01HL041654PubMed and NIHNIH RePORTER

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12698218
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.
J Am Soc Echocardiogr1989https://conductscience.org/library/papers/2698218PubMed
211057435Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.J Hypertens2000https://conductscience.org/library/papers/11057435PubMed
39040574Blood-pressure control in the hypertensive population.Lancet1997https://conductscience.org/library/papers/9040574PubMed
48712120Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).Am J Cardiol1996https://conductscience.org/library/papers/8712120PubMed
51401629Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.J Am Coll Cardiol1992https://conductscience.org/library/papers/1401629PubMed
619361968Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study.Nutr Metab Cardiovasc Dis2009https://conductscience.org/library/papers/19361968PubMed
719502281Identifying needs and opportunities for advancing translational research in cardiovascular disease.Cardiovasc Res2009https://conductscience.org/library/papers/19502281PubMed
819231334Temporal obesity trends in patients undergoing transthoracic echocardiography 2002-2006.Am J Cardiol2009https://conductscience.org/library/papers/19231334PubMed
915323062Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.Am J Hypertens2004https://conductscience.org/library/papers/15323062PubMed
1023032140Determinants of blood pressure treatment and control in obese people: evidence from the general population.J Hypertens2012https://conductscience.org/library/papers/23032140PubMed
1121775111Impact of overweight and obesity on cardiac benefit of antihypertensive treatment.Nutr Metab Cardiovasc Dis2013https://conductscience.org/library/papers/21775111PubMed
1216208150Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.J Hypertens2005https://conductscience.org/library/papers/16208150PubMed
1318794402Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies.Circulation2008https://conductscience.org/library/papers/18794402PubMed
1415326072Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.Circulation2004https://conductscience.org/library/papers/15326072PubMed
152936235Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.Am J Cardiol1986https://conductscience.org/library/papers/2936235PubMed
1622573071Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.J Hypertens2012https://conductscience.org/library/papers/22573071PubMed
1711403367Regression of left ventricular hypertrophy in human hypertension with irbesartan.J Hypertens2001https://conductscience.org/library/papers/11403367PubMed
1823032141Prognostic value of the extent of left ventricular hypertrophy and its evolution in the hypertensive patient.J Hypertens2012https://conductscience.org/library/papers/23032141PubMed
192136980Does increased blood pressure cause left ventricular hypertrophy or vice versa?Ann Intern Med1990https://conductscience.org/library/papers/2136980PubMed
2014678345Differences between clinical trials and postmarketing use.Br J Clin Pharmacol2004https://conductscience.org/library/papers/14678345PubMed

See all 42 referencesDownload CSV of references

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
39296817The Pandora's Box of Hypertensive Heart Disease in Women.JACC Adv2024https://conductscience.org/library/papers/39296817PubMed
38963706The use of echocardiography compared to electrocardiogram when screening for left ventricular hypertrophy in hypertensive patients: A cross-sectional study.J Clin Hypertens (Greenwich)2024https://conductscience.org/library/papers/38963706PubMed
38946010Electrocardiographic tracking of left ventricular hypertrophy in hypertension: incidence and prognostic outcomes from the SPRINT trial.Clin Hypertens2024https://conductscience.org/library/papers/38946010PubMed
38571722The cardiovascular changes underlying a low cardiac output with exercise in patients with type 2 diabetes mellitus.Front Physiol2024https://conductscience.org/library/papers/38571722PubMed
38238511Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension.Hypertens Res2024https://conductscience.org/library/papers/38238511PubMed
38205639Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications.Arterioscler Thromb Vasc Biol2024https://conductscience.org/library/papers/38205639PubMed
37794691Influence of hypertension and global or abdominal obesity on left ventricular hypertrophy: A cross-sectional study.J Clin Hypertens (Greenwich)2024https://conductscience.org/library/papers/37794691PubMed
37342440Hypertensive heart disease: risk factors, complications and mechanisms.Front Cardiovasc Med2023https://conductscience.org/library/papers/37342440PubMed
36917110Association of High Normal Body Weight in Youths With Risk of Hypertension.JAMA Netw Open2023https://conductscience.org/library/papers/36917110PubMed
36606285Prognostic implication of left ventricular hypertrophy regression after antihypertensive therapy in patients with hypertension.Front Cardiovasc Med2022https://conductscience.org/library/papers/36606285PubMed
36136303Sex differences in arterial hypertension.Eur Heart J2022https://conductscience.org/library/papers/36136303PubMed
36082119Sex differences in hypertension. Do we need a sex-specific guideline?Front Cardiovasc Med2022https://conductscience.org/library/papers/36082119PubMed
36030347Sex, gender, and subclinical hypertensiveorgan damage-heart.J Hum Hypertens2023https://conductscience.org/library/papers/36030347PubMed
35788967Cardiovascular Disease Risk Reduction and Body Mass Index.Curr Hypertens Rep2022https://conductscience.org/library/papers/35788967PubMed
35043688Carotid Atherosclerosis Predicts Blood Pressure Control in Patients With Hypertension: The Campania Salute Network Registry.J Am Heart Assoc2022https://conductscience.org/library/papers/35043688PubMed
35032013High incidence of hypertension-mediated organ damage in a series of Chinese patients with 17α-hydroxylase deficiency.Endocrine2022https://conductscience.org/library/papers/35032013PubMed
34733358Hypertension in Women: Should There be a Sex-specific Threshold?Eur Cardiol2021https://conductscience.org/library/papers/34733358PubMed
34426850Left Ventricular Measurements and Strain in Pediatric Patients Evaluated for Systemic Hypertension and the Effect of Adequate Anti-hypertensive Treatment.Pediatr Cardiol2022https://conductscience.org/library/papers/34426850PubMed
34081212Prognostic Significance of Echocardiographic Measures of Cardiac Remodeling in the Community.Curr Cardiol Rep2021https://conductscience.org/library/papers/34081212PubMed
32889649A Contemporary Approach to Hypertensive Cardiomyopathy: Reversing Left Ventricular Hypertrophy.Curr Hypertens Rep2020https://conductscience.org/library/papers/32889649PubMed

See all 40 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
AP2B1163PubTator's text mininghttps://conductscience.org/library/genes/163NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23744404

GET https://conductscience.org/api/papers/v1/23744404/references?page=2